The AI & Big Data in healthcare market is expected to grow at a remarkable CAGR of 36.7% from 2025 to 2030. Valued at USD 14.5 billion in 2024, this market is expanding due to the increasing adoption of AI in predictive modeling and data analytics. Healthcare providers and research institutions are leveraging AI to analyze vast amounts of data for better decision-making, particularly in disease prediction and personalized medicine. The COVID-19 pandemic highlighted the importance of big data in tracking disease patterns and predicting healthcare resource needs.
Product Insights
Predictive modeling applications dominated the market with a revenue share of 44.8% in 2024, as AI is increasingly used to forecast patient outcomes and optimize treatment plans. Data analytics platforms are also on the rise, as hospitals and research institutions seek to leverage AI to gain insights from large datasets, particularly for drug development and precision medicine.
Regional Insights
North America remains the largest market for AI and Big Data in healthcare, holding a 41.2% share in 2024, with widespread adoption of AI tools in clinical settings. Asia Pacific is expected to witness the fastest growth, with a CAGR of 40.5%, driven by increasing investments in AI technology and healthcare innovation.